Table 3.
Association of hormone receptor expression with FGT proportion and BPE
| Estrogen Receptor | Progesterone Receptor | HER2 Status | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| ER− (%) | ER+ (%) | p | PR− (%) | PR+ (%) | p | HER2− (%) | HER2+ (%) | p | ||
| All Patients | FGT proportion | 0.009 | 0.256 | 0.453 | ||||||
| Fatty | 12 (34.3) | 23 (65.7) | 13 (37.1) | 22 (62.9) | 24 (68.6) | 11 (31.4) | ||||
| High Fibroglandular | 3 (7.5) | 37 (92.5) | 9 (22.5) | 31 (77.5) | 23 (57.5) | 17 (42.5) | ||||
| BPE | 0.018 | 0.013 | 0.922 | |||||||
| Low BPE | 13 (28.9) | 32 (71.1) | 18 (40) | 27 (60) | 28 (62.2) | 17 (37.8) | ||||
| High BPE | 2 (6.7) | 28 (93.3) | 4 (13.3) | 26 (86.7) | 19 (63.3) | 11 (36.7) | ||||
| Premenopausal Patients | FGT proportion | 0.005 | 0.050 | 0.974 | ||||||
| Fatty | 7 (41.2) | 10 (58.8) | 8 (47.1) | 9 (52.9) | 12 (70.6) | 5 (29.4) | ||||
| High Fibroglandular | 2 (6.3) | 30 (93.8) | 6 (18.8) | 26 (81.3) | 21 (65.6) | 11 (34.4) | ||||
| BPE | 0.011 | 0.021 | 1.000 | |||||||
| Low BPE | 8 (33.3) | 16 (66.7) | 11 (45.8) | 13 (54.2) | 16 (66.7) | 8 (33.3) | ||||
| High BPE | 1 (4) | 24 (96) | 3 (12) | 22 (88) | 17 (68) | 8 (32) | ||||
| Postmenopausal Patients | FGT Proportion | 0.628 | 0.668 | 0.090 | ||||||
| Fatty | 5 (27.8) | 13 (72.2) | 5 (27.8) | 13 (72.2) | 12 (66.7) | 6 (33.3) | ||||
| High Fibroglandular | 1 (12.5) | 7 (87.5) | 3 (37.5) | 5 (62.5) | 2 (25) | 6 (75) | ||||
| BPE | 1.000 | 1.000 | 0.635 | |||||||
| Low BPE | 5 (23.8) | 16 (76.2) | 7 (33.3) | 14 (66.7) | 12 (57.1) | 9 (42.9) | ||||
| High BPE | 1 (20) | 4 (80) | 1 (20) | 4 (80) | 2 (40) | 3 (60) | ||||
ER: estrogen receptor; PR: progesterone receptor; HER2: human epidermal growth factor 2-neu; BPE: background parenchymal enhancement